These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29954145)

  • 21. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
    Van den Kerkhof M; Mabille D; Chatelain E; Mowbray CE; Braillard S; Hendrickx S; Maes L; Caljon G
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):81-86. PubMed ID: 29425734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
    de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
    J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
    Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
    Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileishmanial efficacy and tolerability of combined treatment with non-ionic surfactant vesicle formulations of sodium stibogluconate and paromomycin in dogs.
    Miret JA; Moreno J; Nieto J; Carter KC; Mullen AB; Ambros L; Rodríguez C; San Andrés MI; González F
    Exp Parasitol; 2021 Jan; 220():108033. PubMed ID: 33166530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro drug susceptibility using a parasite-rescue and transformation assay of Leishmania (Mundinia) martiniquensis and Leishmania (Mundinia) orientalis amastigotes against antileishmanial drugs.
    Kimcharoensuk S; Leelayoova S; Mungthin M; Nawattanapaibool N; Tan-Ariya P; Siripattanapipong S
    Acta Trop; 2024 Jan; 249():107081. PubMed ID: 37993039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
    Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
    Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
    Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
    Albassam AA; Frye RF; Markowitz JS
    Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani.
    Bansal R; Sen SS; Muthuswami R; Madhubala R
    J Antimicrob Chemother; 2020 Apr; 75(4):942-950. PubMed ID: 31886855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188.
    Espuelas S; Legrand P; Loiseau PM; Bories C; Barratt G; Irache JM
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2190-2. PubMed ID: 10898700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B.
    Valdivieso E; Mejías F; Carrillo E; Sánchez C; Moreno J
    Int J Antimicrob Agents; 2018 Nov; 52(5):682-687. PubMed ID: 29969693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
    Mesquita JT; Tempone AG; Reimão JQ
    Acta Trop; 2014 Feb; 130():112-6. PubMed ID: 24239532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
    Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
    Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.
    Nicoletti S; Seifert K; Gilbert IH
    Int J Antimicrob Agents; 2009 May; 33(5):441-8. PubMed ID: 19097763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes.
    Prajapat VM; Aalhate M; Sriram A; Mahajan S; Maji I; Gupta U; Kumari D; Singh K; Kalia NP; Dua K; Singh SK; Singh PK
    Parasitol Int; 2024 Jun; 100():102848. PubMed ID: 38159836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.